Daniel J. O'connor

Optometry
4630 Village Square Dr
Suite 100
Paducah, KY 42001

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Recommendations for the use of clinical outcome assessments in rare disease drug development.

Recommendations for the use of clinical outcome assessments in rare disease drug development.

Journal: EClinicalMedicine
Published: March 05, 2026

Unlocking the potential of disease prevention through regulatory science.

Unlocking the potential of disease prevention through regulatory science.

Journal: Nature reviews. Drug discovery
Published: February 10, 2026

Editorial: The changing focus of regulatory frameworks around the globe and the opportunities for harmonization.

Editorial: The changing focus of regulatory frameworks around the globe and the opportunities for harmonization.

Journal: Frontiers in medicine
Published: June 11, 2025

The Rare Therapies Launchpad: a pilot program for individualized medicines in the UK.

The Rare Therapies Launchpad: a pilot program for individualized medicines in the UK.

Journal: Nature medicine
Published: March 11, 2025

Personalized medicine: when the common becomes the rare.

Personalized medicine: when the common becomes the rare.

Journal: Frontiers in medicine
Published: November 06, 2024

Drug-device combinations in rare diseases: Challenges and opportunities.

Drug-device combinations in rare diseases: Challenges and opportunities.

Journal: Drug discovery today
Published: October 02, 2024

IRDiRC Drug Repurposing Guidebook: making better use of existing drugs to tackle rare diseases.

IRDiRC Drug Repurposing Guidebook: making better use of existing drugs to tackle rare diseases.

Journal: Nature reviews. Drug discovery
Published: October 23, 2023

Defining rare conditions in the era of personalized medicine.

Defining rare conditions in the era of personalized medicine.

Journal: Nature reviews. Drug discovery
Published: September 08, 2023

Guidelines for cellular and molecular pathology content in clinical trial protocols: the SPIRIT-Path extension.

Guidelines for cellular and molecular pathology content in clinical trial protocols: the SPIRIT-Path extension.

Journal: The Lancet. Oncology
Published: May 07, 2021

The important role of the histopathologist in clinical trials: challenges and approaches to tackle them.

The important role of the histopathologist in clinical trials: challenges and approaches to tackle them.

Journal: Histopathology
Published: March 08, 2020

Harnessing the patient voice in real-world evidence: the essential role of patient-reported outcomes.

Harnessing the patient voice in real-world evidence: the essential role of patient-reported outcomes.

Journal: Nature reviews. Drug discovery
Published: October 02, 2019

Eligibility criteria in haematological cancer clinical trials-what's needed?

Eligibility criteria in haematological cancer clinical trials-what's needed?

Journal: The Lancet. Haematology
Published: June 04, 2019
Showing 1-12 of 16

Last Updated: 09/26/2026